March 29, 2006 Citigroup Global Markets Inc. As Representative of the Initial Purchasers c/o Citigroup Global Markets Inc. 390 Greenwich Street New York, New York 10013 Ladies and Gentlemen: This Registration Rights Agreement (the "Agreement") is made...Registration Rights Agreement • March 30th, 2006 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
CONFORMED COPY CREDIT AGREEMENT Dated as of February 27, 1998, as amended and restated as of December 22, 1998Credit Agreement • March 31st, 1999 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
INDENTUREIndenture • April 27th, 1999 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
1 Exhibit C VOTING AGREEMENT THIS VOTING AGREEMENT (this "Agreement") is entered into this 30th day of November, 1999, by and among KING PHARMACEUTICALS, INC., a Tennessee corporation ("Acquiror"), MERLIN ACQUISITION I CORP., a Delaware corporation...Voting Agreement • December 21st, 1999 • King Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
EXHIBIT 10 JUNE 2002 NOTE PURCHASE AGREEMENT BY AND BETWEENNote Purchase Agreement • July 24th, 2002 • King Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
BY AND AMONGMerger Agreement • December 10th, 1999 • King Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AND THE BANK OF NEW YORK TRUST COMPANY, N.A., AS TRUSTEEIndenture • March 30th, 2006 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
for Corgard(R) between BRISTOL-MYERS SQUIBB COMPANY as Seller, and KING PHARMACEUTICALS, INC. as PurchaserAsset Purchase Agreement • August 24th, 2001 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
ARTICLE IAsset Purchase Agreement • October 24th, 1997 • King Pharmaceuticals Inc • Missouri
TRADEMARK, PATENT, COPYRIGHT AND KNOW-HOW LICENSE AGREEMENT betweenLicense Agreement • January 9th, 1998 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 8 SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this "Agreement") is dated as of this 26th day of June, 2002, by and between NOVAVAX, INC., a Delaware corporation (the...Registration Rights Agreement • July 24th, 2002 • King Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AGREEMENT FORPurchase and Sale Agreement • January 9th, 1998 • King Pharmaceuticals Inc • Pharmaceutical preparations • North Carolina
October 31, 1997 CONFIDENTIAL Mr. John A.A. Bellamy Executive Vice President & General Counsel King Pharmaceuticals, Inc. 501 Fifth Street Bristol, Tennessee 37620 Re: Proposed Acquisition of the Parkedale Facility and Certain Products Dear Mr....Acquisition Agreement • January 9th, 1998 • King Pharmaceuticals Inc • Pharmaceutical preparations
LOAN AGREEMENTLoan Agreement • October 24th, 1997 • King Pharmaceuticals Inc • Tennessee
FOURTH AMENDMENT ---------------- dated as of October 24, 2000 to theCredit Agreement • April 2nd, 2001 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
1 EXHIBIT 10.15 CREDIT AGREEMENTCredit Agreement • December 9th, 1997 • King Pharmaceuticals Inc • Pharmaceutical preparations • Georgia
INDENTUREIndenture • July 3rd, 2001 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
CONFIDENTIALAsset Purchase Agreement • June 30th, 2000 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
RECITALSLicense Agreement • May 7th, 1998 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
FORM OF UNDERWRITING AGREEMENTUnderwriting Agreement • December 9th, 1997 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 10.20 CREDIT AGREEMENT Dated as of April 23, 2002,Credit Agreement • May 15th, 2002 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
KING PHARMACEUTICALS, INC. and UNION PLANTERS NATIONAL BANK Rights AgentRights Agreement • October 24th, 1997 • King Pharmaceuticals Inc • Tennessee
EXHIBIT 7 CONVERTIBLE NOTE THIS NOTE AND THE SHARES OF COMMON STOCK OF NOVAVAX, INC. (OR OTHER SECURITIES) WHICH MAY BE ISSUABLE AS INTEREST ON OR UPON CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE...Convertible Note • July 24th, 2002 • King Pharmaceuticals Inc • Pharmaceutical preparations
BY AND AMONGMerger Agreement • July 26th, 2004 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
AGREEMENT FOR PURCHASE AND SALE OF ASSETS RELATING TO NEOSPORIN(R) AND POLYSPORIN(R) BY AND BETWEEN GLAXO WELLCOME INC. AND MONARCH PHARMACEUTICALS, INC.Purchase and Sale Agreement • January 9th, 1998 • King Pharmaceuticals Inc • Pharmaceutical preparations • North Carolina
BY AND BETWEEN NOVAVAX, INC. ANDRegistration Rights Agreement • December 29th, 2000 • King Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
andIndenture • February 4th, 2002 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
1 EXHIBIT 10.10 LOAN AND SECURITY AGREEMENT BY AND BETWEEN KING PHARMACEUTICALS, INC., AS BORROWERLoan and Security Agreement • October 24th, 1997 • King Pharmaceuticals Inc • Tennessee
NOVAVAX, INC. ANDNote Purchase Agreement • December 29th, 2000 • King Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
EXHIBIT 2.1 AMENDED AND RESTATED ASSET PURCHASE AGREEMENTAsset Purchase Agreement • June 13th, 2003 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
AGREEMENTSLoan Agreement • October 24th, 1997 • King Pharmaceuticals Inc • Tennessee
July 30, 1997Investment Banking Agreement • October 24th, 1997 • King Pharmaceuticals Inc
AGREEMENT FORPurchase and Sale Agreement • January 8th, 2001 • King Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGERMerger Agreement • October 12th, 2010 • King Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of October 11, 2010 among Pfizer Inc., a Delaware corporation (“Parent”), King Pharmaceuticals, Inc., a Tennessee corporation (the “Company”), and Parker Tennessee Corp., a Tennessee corporation and a subsidiary of Parent owned directly by Parent and/or indirectly by Parent through one or more of its wholly-owned subsidiaries (“Merger Sub”).
EXECUTION VERSION FIRST AMENDMENT dated as of March 22, 2006 (this "Amendment") to the CREDIT AGREEMENT dated as of April 23, 2002 (as amended, supplemented or otherwise modified from time to time, the "Credit Agreement"), among KING PHARMACEUTICALS,...Credit Agreement • March 28th, 2006 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
